The underlying mechanisms likely involve the NFκB-regulated chemokine expression, since several studies have demonstrated that the expression of CCL2, CXCL1, CXCL2, and IL-8/CXCL8 is mediated by NFκB in ovarian cancer cells [28,29,30,41]. This evidence concerns the gene CXCL2 and ovarian carcinoma.